Gas and gas-generating nanoplatforms in cancer therapy
Gas therapy is the usage of certain gases with special therapeutic effects for the treatment of diseases. Hydrogen (H 2 ), nitric oxide (NO), carbon monoxide (CO), and hydrogen sulfide (H 2 S) acting as gas signalling molecules are representative gases in cancer therapy. They act directly on mitocho...
Saved in:
Published in | Journal of materials chemistry. B, Materials for biology and medicine Vol. 9; no. 41; pp. 8541 - 8557 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
England
Royal Society of Chemistry
27.10.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Gas therapy is the usage of certain gases with special therapeutic effects for the treatment of diseases. Hydrogen (H
2
), nitric oxide (NO), carbon monoxide (CO), and hydrogen sulfide (H
2
S) acting as gas signalling molecules are representative gases in cancer therapy. They act directly on mitochondria or nuclei to lead to cell apoptosis. They can also alleviate immuno-suppression in the tumour microenvironment and promote phenotype conversion of tumour-associated macrophages. Moreover, the combination of gas therapy and other traditional therapy methods can reduce side effects and improve therapeutic efficacy. Here, we discuss the roles of NO, CO, H
2
S and H
2
in cancer biology. Considering the rapidly developing nanotechnology, gas-generating nanoplatforms which can achieve targeted delivery and controlled release were also discussed. Finally, we highlight the current challenges and future opportunities of gas-based cancer therapy.
Gas-generating nanoplatforms have promising therapeutic potential for cancer treatment. |
---|---|
Bibliography: | Dr Zhi-Jun Sun received his doctoral degree from Wuhan University in 2006 and was a visiting postdoctoral fellow at the National Institutes of Health (NIH) in Bethesda (2009-2012). He is working as a professor (2013 to present) at Wuhan University. He has published more than 130 peer-reviewed articles, and his research interests include the mechanism of tumor immune evasion and the use of nanomaterials to enhance anti-tumor immunity. Yuan-Zhe Jing was born in Beijing, China, in 1994. She received her master's degree from Wuhan University in 2021 under the guidance of Prof. Zhi-Jun Sun. Presently her research interest is focused on gas therapy and gas-generating nanoplatforms in cancer therapy. Shu-Jin Li was born in Jiangsu, China, in 1998. He received his BS degree (2021) in Stomatology from Wuhan University. He is currently a PhD student working under Prof. Zhi-Jun Sun's supervision at Wuhan University. His current research focuses on improving the efficacy of immuno-checkpoint inhibitors in oral cancer. ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
ISSN: | 2050-750X 2050-7518 |
DOI: | 10.1039/d1tb01661j |